ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

MGBX First English Twitter Space: Trading Strategies Special Talk with Crypto Blood

MGBX held its first English Twitter Space on August 28 to share market views and product updates with a global audience. The guest speaker was crypto creator Crypto Blood, known in the community for sharp analysis and a pragmatic trading approach.

At the outset, the host recapped MGBX product evolution since 2019—from continuous iteration in spot, futures, and AI copy trading to recent upgrades to the smart copy-trading system and a refreshed UI aimed at a smoother trading experience. During the Space, MGBX also announced plans to appear at TOKEN2049 Singapore for in-person engagement with overseas users.

The discussion centered on Crypto Blood personal journey, his read on the market, and practical advice for investors. The session was lively and tightly paced, with Q&A pushing the conversation deeper.

Crypto Blood began with his background and the origin of Bloodalytics. He entered crypto in 2013 after building a systematic approach in U.S. equities and FX; leveraging a software engineering background, he used MT4 EAs for semi-automated trading early on. With limited tooling in the early crypto days, he moved to TradingView and Pine Script to codify rules for entries, stop losses, and staged take-profits, iterating toward what became Bloodalytics—designed not only to give himself reliable, testable signals, but also to help others adopt the same method with less trial and error.

He then outlined guidance for newcomers. The most common pitfalls, he said, are blurring the line between investing and trading, lacking strict stops, and operating without a coherent system. The way out is to build and validate an executable framework (backtesting + forward testing) and put risk management first.

Turning to the market backdrop, the host and Crypto Blood discussed the current environment. His view: deeper institutional participation has tightened crypto linkage with U.S. equities, with ETF flows shaping short-term rhythm and making structural dispersion more frequent. In earlier years crypto correlation with Wall Street was low; as participation and ETF grew, more flow originates from Wall Street and portfolio rebalancing happens more often—on weak equity days, capital may sell crypto to offset losses or raise cash. As a result, Nasdaq futures have become his morning temperature check; compared with the S&P 500, he sees Nasdaq as more closely aligned with crypto daily direction.

He also flagged a notable shift: ETH relative strength and a tentative decoupling from BTC. In his multi-year observation, such magnitude is uncommon and looks like rotation from BTC toward ETH ETF, alongside a market re-pricing of risks tied to large BTC-exposed entities. In extreme scenarios, forced reductions could spark price-level chain reactions. Barring a clear downturn in equities, he leans toward a phase where ETH outperforms; if U.S. stocks roll over, the risk-off spillover to crypto warrants caution. From a role standpoint, short-term traders mainly need volatility and a system to go long or short; long-horizon investors are more exposed to drawdowns and should keep dry powder and add in tranches at lower levels. Methods can vary by person, he noted, but risk management ultimately defines the experience.

Lastly, Crypto Blood shared his opinion on what makes a good exchange into three points: stability and fairness (accurate charts/quotes, no outages, no stop-hunting), security and operations, and the test of time. On derivatives, he returned to fundamentals: risk control / money management / execution discipline. As for working with MGBX, he described the experience as positive, citing the platform’s openness in copy trading and reliable product craftsmanship, and looks forward to integrating HedgeLytics low-risk signals into copy trading while exploring synergies with wealth-management features.

In closing, the host emphasized that MGBX will continue to optimize products, accelerate spots trading development, and improve the copy-trading stack to further improve user experience. For more updates and events, visit https://www.mgbx.com/ or follow the official X (Twitter) account @MGBX_EN for first-hand news. Through steady iteration and global expansion, MGBX aims to deliver on its commitments—Beyond trading, your long-term partner in crypto.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.